Silk nanoparticles - an emerging anticancer nanomedicine

Research output: Contribution to journalArticle

211 Downloads (Pure)

Abstract

Silk is a sustainable and ecologically friendly biopolymer with a robust clinical track record in humans for load bearing applications, in part due to its excellent mechanical properties and biocompatibility. Our ability to take bottom-up and top-down approaches for the generation of silk (inspired) biopolymers has been critical in supporting the evolution of silk materials and formats, including silk nanoparticles for drug delivery. Silk nanoparticles are emerging as interesting
contenders for drug delivery and are well placed to advance the nanomedicine field. This review covers the use of Bombyx mori and recombinant silks as an anticancer nanomedicine, highlighting the emerging trends and developments as well as critically assessing the current opportunities and challenges by providing a context specific assessment of this multidisciplinary field.
Original languageEnglish
Pages (from-to)239-258
Number of pages20
JournalAIMS Bioengineering
Volume42
Issue number2
DOIs
Publication statusPublished - 22 Mar 2017

Keywords

  • silk
  • fibroin
  • nanomedicine
  • nanoparticle
  • drug delivery
  • Bombyx mori
  • targeting
  • EPR
  • endocytosis

Fingerprint Dive into the research topics of 'Silk nanoparticles - an emerging anticancer nanomedicine'. Together they form a unique fingerprint.

  • Projects

    Cite this